摘要:
The present invention is directed toward a neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
摘要:
The present invention is directed toward a neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
摘要:
The present invention is directed toward a neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
摘要:
The present invention is directed toward a neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
摘要:
The present invention is directed toward a neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
摘要:
Disclosed are a display device and a control method thereof. The display device includes a display, a camera capturing a gesture in a three dimensional space; and a controller selectively displaying a virtual keyboard corresponding to a hand gesture for character input on the display when the captured gesture includes the hand gesture for the character input. Accordingly, the virtual keyboard corresponding to the hand gesture for the character input is displayed, so that the user may not perform an additional operation to display the virtual keyboard.
摘要:
Disclosed are a light conversion member, a display device including the same, and a method for fabricating the same. The light conversion member includes a host, a plurality of light conversion particles in the host, and a ferroelectric material in the host.
摘要:
The present invention is directed toward a neutralizing monoclonal antibody to basic fibroblast growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
摘要:
A method for measuring human intelligence using a neurobiogical model is provided. The method enables neurometric IQ to be measured by processing MRI and fMRI images of a subject to determine cortical thicknesses and brain activation level, determining structural IQ (sIQ) and functional IQ (fIQ) from the determined cortical thicknesses and brain activation level, and using the structural IQ (sIQ) and the functional IQ (fIQ) as predictors to measure the neurometric IQ of the subject. With this, individual differences in general cognitive ability can be easily assessed. It suggests that general cognitive ability can be explained by two different neural bases or traits: facilitation of neural circuits and accumulation of crystallized knowledge.
摘要:
The present invention provides monoclonal antibodies, and portions thereof, which are capable of specifically binding to human vascular endothelial cell growth factor (hVEGF) or hVEGF-related protein. The invention also provides hybridoma cell lines that produce such monoclonal antibodies. The monoclonal antibodies of the invention are useful as therapeutic agents either by themselves or in conjunction with cytotoxic or other chemotherapeutic agents, to treat diseases that are characterized by excessive vascular endothelial cell proliferation. The monoclonal antibodies of the invention also are useful in diagnostic and analytical methods for determining the presence of hVEGF or hVEGF related-protein in a test sample.